David BRASSAT

David Brassat is a Senior Clinical Development Medical Director with extensive experience in neurology and medical affairs. They served as a Principal Global Medical Director at Roche from 2021 to 2023 and as a Medical Director at Biogen from 2019 to 2021. Currently, David is a Senior Consultant at AP-HP and a Senior Medical Director in drug development at Novartis, where they lead research on Multiple Sclerosis biomarkers and oversee clinical trials. Additionally, David was a Full Professor of Neurology at University Paul Sabatier in Toulouse, France, from 2004 to 2019. They hold multiple advanced degrees, including an MD-PhD in Neurology and Immunogenetics.